{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:14:42Z","timestamp":1792030482871,"version":"4.4.0"},"reference-count":235,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,3,6]],"date-time":"2015-03-06T00:00:00Z","timestamp":1425600000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Front. Med."],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s11684-015-0386-y","type":"journal-article","created":{"date-parts":[[2015,3,6]],"date-time":"2015-03-06T10:10:57Z","timestamp":1425636657000},"page":"187-219","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Autoimmune hepatitis"],"prefix":"10.1007","volume":"9","author":[{"given":"Farhad","family":"Sahebjam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Vierling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,6]]},"reference":[{"issue":"6","key":"386_CR1","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","volume":"51","author":"MP Manns","year":"2010","unstructured":"Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, Vierling JM. Diagnosis and management of autoimmune hepatitis. Hepatology 2010; 51(6): 2193\u20132213","journal-title":"Hepatology"},{"issue":"1","key":"386_CR2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000347211","volume":"31","author":"CP Strassburg","year":"2013","unstructured":"Strassburg CP. Autoimmune hepatitis. Dig Dis 2013; 31(1): 155\u2013163","journal-title":"Dig Dis"},{"issue":"9902","key":"386_CR3","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0140-6736(12)62163-1","volume":"382","author":"MA Heneghan","year":"2013","unstructured":"Heneghan MA, Yeoman AD, Verma S, Smith AD, Longhi MS. Autoimmune hepatitis. Lancet 2013; 382(9902): 1433\u20131444","journal-title":"Lancet"},{"issue":"6","key":"386_CR4","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bpg.2011.09.008","volume":"25","author":"JA Ilyas","year":"2011","unstructured":"Ilyas JA, O\u2019Mahony CA, Vierling JM. Liver transplantation in autoimmune liver diseases. Best Pract Res Clin Gastroenterol 2011; 25(6): 765\u2013782","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"2","key":"386_CR5","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","volume":"36","author":"AJ Czaja","year":"2002","unstructured":"Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002; 36(2): 479\u2013497","journal-title":"Hepatology"},{"issue":"1","key":"386_CR6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11894-011-0236-2","volume":"14","author":"JM Vierling","year":"2012","unstructured":"Vierling JM. Diagnosis and treatment of autoimmune hepatitis. Curr Gastroenterol Rep 2012; 14(1): 25\u201336","journal-title":"Curr Gastroenterol Rep"},{"issue":"3","key":"386_CR7","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S1089-3261(02)00021-1","volume":"6","author":"KM Boberg","year":"2002","unstructured":"Boberg KM. Prevalence and epidemiology of autoimmune hepatitis. Clin Liver Dis 2002; 6(3): 635\u2013647","journal-title":"Clin Liver Dis"},{"issue":"4","key":"386_CR8","first-page":"402","volume":"72","author":"J Primo","year":"2009","unstructured":"Primo J, Maroto N, Mart\u00ednez M, Ant\u00f3n MD, Zaragoza A, Giner R, Devesa F, Merino C, del Olmo JA. Incidence of adult form of autoimmune hepatitis in Valencia (Spain). Acta Gastroenterol Belg 2009; 72(4): 402\u2013406","journal-title":"Acta Gastroenterol Belg"},{"issue":"11","key":"386_CR9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/1751-2980.12085","volume":"14","author":"JS Delgado","year":"2013","unstructured":"Delgado JS, Vodonos A, Malnick S, Kriger O, Wilkof-Segev R, Delgado B, Novack V, Rosenthal A, Menachem Y, Melzer E, Fich A. Autoimmune hepatitis in southern Israel: a 15-year multicenter study. J Dig Dis 2013; 14(11): 611\u2013618","journal-title":"J Dig Dis"},{"issue":"9","key":"386_CR10","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/j.1572-0241.2002.06019.x","volume":"97","author":"KJ Hurlburt","year":"2002","unstructured":"Hurlburt KJ, McMahon BJ, Deubner H, Hsu-Trawinski B, Williams JL, Kowdley KV. Prevalence of autoimmune liver disease in Alaska Natives. Am J Gastroenterol 2002; 97(9): 2402\u20132407","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"386_CR11","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1089-3261(02)00019-3","volume":"6","author":"IG McFarlane","year":"2002","unstructured":"McFarlane IG. Autoimmune hepatitis: diagnostic criteria, subclassifications, and clinical features. Clin Liver Dis 2002; 6(3): 605\u2013621","journal-title":"Clin Liver Dis"},{"issue":"3","key":"386_CR12","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510250308","volume":"25","author":"GV Gregorio","year":"1997","unstructured":"Gregorio GV, Portmann B, Reid F, Donaldson PT, Doherty DG, McCartney M, Mowat AP, Vergani D, Mieli-Vergani G. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 1997; 25(3): 541\u2013547","journal-title":"Hepatology"},{"issue":"8","key":"386_CR13","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1111\/j.1572-0241.2002.05921.x","volume":"97","author":"AJ Czaja","year":"2002","unstructured":"Czaja AJ, Donaldson PT. Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis. Am J Gastroenterol 2002; 97(8): 2051\u20132057","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"386_CR14","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0016-5085(92)90041-V","volume":"103","author":"T Seki","year":"1992","unstructured":"Seki T, Ota M, Furuta S, Fukushima H, Kondo T, Hino K, Mizuki N, Ando A, Tsuji K, Inoko H, et al. HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients. Gastroenterology 1992; 103(3): 1041\u20131047","journal-title":"Gastroenterology"},{"issue":"10","key":"386_CR15","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1440-1746.2010.06384.x","volume":"25","author":"JH Ngu","year":"2010","unstructured":"Ngu JH, Bechly K, Chapman BA, Burt MJ, Barclay ML, Gearry RB, Stedman CA. Population-based epidemiology study of autoimmune hepatitis: a disease of older women? J Gastroenterol Hepatol 2010; 25(10): 1681\u20131686","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"386_CR16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1586\/egh.13.21","volume":"7","author":"AJ Czaja","year":"2013","unstructured":"Czaja AJ. Autoimmune hepatitis in diverse ethnic populations and geographical regions. Expert Rev Gastroenterol Hepatol 2013; 7(4): 365\u2013385","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"5","key":"386_CR17","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/gut.50.5.713","volume":"50","author":"T Zolfino","year":"2002","unstructured":"Zolfino T, Heneghan MA, Norris S, Harrison PM, Portmann BC, McFarlane IG. Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin. Gut 2002; 50(5): 713\u2013717","journal-title":"Gut"},{"issue":"12","key":"386_CR18","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1111\/j.1572-0241.2001.05272.x","volume":"96","author":"KN Lim","year":"2001","unstructured":"Lim KN, Casanova RL, Boyer TD, Bruno CJ. Autoimmune hepatitis in African Americans: presenting features and response to therapy. Am J Gastroenterol 2001; 96(12): 3390\u20133394","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"386_CR19","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/hep.21884","volume":"46","author":"S Verma","year":"2007","unstructured":"Verma S, Torbenson M, Thuluvath PJ. The impact of ethnicity on the natural history of autoimmune hepatitis. Hepatology 2007; 46(6): 1828\u20131835","journal-title":"Hepatology"},{"issue":"5","key":"386_CR20","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1440-1746.1998.tb00674.x","volume":"13","author":"K Nakamura","year":"1998","unstructured":"Nakamura K, Yoneda M, Yokohama S, Tamori K, Sato Y, Aso K, Aoshima M, Hasegawa T, Makino I. Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis. J Gastroenterol Hepatol 1998; 13(5): 490\u2013495","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"386_CR21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1586\/egh.12.17","volume":"6","author":"R Liberal","year":"2012","unstructured":"Liberal R, Vergani D. Effect of ethnicity on the clinical presentation and outcome of autoimmune hepatitis. Expert Rev Gastroenterol Hepatol 2012; 6(3): 267\u2013269","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"386_CR22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3892\/etm.2013.1363","volume":"7","author":"M Peng","year":"2014","unstructured":"Peng M, Li Y, Zhang M, Jiang Y, Xu Y, Tian Y, Peng F, Gong G. Clinical features in different age groups of patients with autoimmune hepatitis. Exp Ther Med 2014; 7(1): 145\u2013148","journal-title":"Exp Ther Med"},{"issue":"2","key":"386_CR23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/apt.12563","volume":"39","author":"J Chen","year":"2014","unstructured":"Chen J, Eslick GD, Weltman M. Systematic review with metaanalysis: clinical manifestations and management of autoimmune hepatitis in the elderly. Aliment Pharmacol Ther 2014; 39(2): 117\u2013124","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"386_CR24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2009.08.010","volume":"34","author":"MS Longhi","year":"2010","unstructured":"Longhi MS, Ma Y, Mieli-Vergani G, Vergani D. Aetiopathogenesis of autoimmune hepatitis. J Autoimmun 2010; 34(1): 7\u201314","journal-title":"J Autoimmun"},{"key":"386_CR25","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaut.2012.11.002","volume":"41","author":"R Liberal","year":"2013","unstructured":"Liberal R, Grant CR, Mieli-Vergani G, Vergani D. Autoimmune hepatitis: a comprehensive review. J Autoimmun 2013; 41: 126\u2013139","journal-title":"J Autoimmun"},{"issue":"5","key":"386_CR26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.autrev.2005.01.005","volume":"4","author":"Y Ichiki","year":"2005","unstructured":"Ichiki Y, Aoki CA, Bowlus CL, Shimoda S, Ishibashi H, Gershwin ME. T cell immunity in autoimmune hepatitis. Autoimmun Rev 2005; 4(5): 315\u2013321","journal-title":"Autoimmun Rev"},{"key":"386_CR27","volume-title":"Autoimmune Hepatitis: A Guide for Practicing Clinicians","author":"JM Vierling","year":"2012","unstructured":"Vierling JM. The pathogenesis of autoimmune hepatitis. In: Hirschfield GM, Heathcote EJ. Autoimmune Hepatitis: A Guide for Practicing Clinicians. New York: Humana Press, 2012"},{"issue":"6","key":"386_CR28","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.bpg.2011.09.009","volume":"25","author":"R Liberal","year":"2011","unstructured":"Liberal R, Longhi MS, Mieli-Vergani G, Vergani D. Pathogenesis of autoimmune hepatitis. Best Pract Res Clin Gastroenterol 2011; 25(6): 653\u2013664","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"4","key":"386_CR29","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s10620-011-1611-4","volume":"56","author":"AJ Czaja","year":"2011","unstructured":"Czaja AJ. Drug-induced autoimmune-like hepatitis. Dig Dis Sci 2011; 56(4): 958\u2013976","journal-title":"Dig Dis Sci"},{"issue":"6","key":"386_CR30","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.23588","volume":"51","author":"E Bj\u00f6rnsson","year":"2010","unstructured":"Bj\u00f6rnsson E, Talwalkar J, Treeprasertsuk S, Kamath PS, Takahashi N, Sanderson S, Neuhauser M, Lindor K. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology 2010; 51(6): 2040\u20132048","journal-title":"Hepatology"},{"issue":"3","key":"386_CR31","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.24481","volume":"54","author":"A Suzuki","year":"2011","unstructured":"Suzuki A, Brunt EM, Kleiner DE, Miquel R, Smyrk TC, Andrade RJ, Lucena MI, Castiella A, Lindor K, Bj\u00f6rnsson E. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology 2011; 54(3): 931\u2013939","journal-title":"Hepatology"},{"issue":"4","key":"386_CR32","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jhep.2010.12.041","volume":"55","author":"MI Lucena","year":"2011","unstructured":"Lucena MI, Kaplowitz N, Hallal H, Castiella A, Garc\u00eda-Bengoechea M, Otazua P, Berenguer M, Fernandez MC, Planas R, Andrade RJ. Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis. J Hepatol 2011; 55(4): 820\u2013827","journal-title":"J Hepatol"},{"issue":"2","key":"386_CR33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3350\/cmh.2012.18.2.213","volume":"18","author":"HY Ju","year":"2012","unstructured":"Ju HY, Jang JY, Jeong SW, Woo SA, Kong MG, Jang HY, Lee SH, Kim SG, Cha SW, Kim YS, Cho YD, Jin SY, Kim HS, Kim BS. The clinical features of drug-induced liver injury observed through liver biopsy: focus on relevancy to autoimmune hepatitis. Clin Mol Hepatol 2012; 18(2): 213\u2013218","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"386_CR34","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2014.04.022","volume":"147","author":"YS Boer de","year":"2014","unstructured":"de Boer YS, van Gerven NM, Zwiers A, Verwer BJ, van Hoek B, van Erpecum KJ, Beuers U, van Buuren HR, Drenth JP, den Ouden JW, Verdonk RC, Koek GH, Brouwer JT, Guichelaar MM, Vrolijk JM, Kraal G, Mulder CJ, van Nieuwkerk CM, Fischer J, Berg T, Stickel F, Sarrazin C, Schramm C, Lohse AW, Weiler-Normann C, Lerch MM, Nauck M, V\u00f6lzke H, Homuth G, Bloemena E, Verspaget HW, Kumar V, Zhernakova A, Wijmenga C, Franke L, Bouma G. Genome-wide association study identifies variants associated with autoimmune hepatitis type 1. Gastroenterology 2014; 147(2): 443\u2013452, e5","journal-title":"Gastroenterology"},{"issue":"4","key":"386_CR35","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.autrev.2008.11.005","volume":"8","author":"C Duarte-Rey","year":"2009","unstructured":"Duarte-Rey C, Pardo AL, Rodr\u00edguez-Velosa Y, Mantilla RD, Anaya JM, Rojas-Villarraga A. HLA class II association with autoimmune hepatitis in Latin America: a meta-analysis. Autoimmun Rev 2009; 8(4): 325\u2013331","journal-title":"Autoimmun Rev"},{"key":"386_CR36","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jaut.2012.12.003","volume":"41","author":"MS Longhi","year":"2013","unstructured":"Longhi MS, Ma Y, Grant CR, Samyn M, Gordon P, Mieli-Vergani G, Vergani D. T-regs in autoimmune hepatitis-systemic lupus erythematosus\/mixed connective tissue disease overlap syndrome are functionally defective and display a Th1 cytokine profile. J Autoimmun 2013; 41: 146\u2013151","journal-title":"J Autoimmun"},{"key":"386_CR37","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2013.06.016","volume":"46","author":"L Muratori","year":"2013","unstructured":"Muratori L, Longhi MS. The interplay between regulatory and effector T cells in autoimmune hepatitis: Implications for innovative treatment strategies. J Autoimmun 2013; 46: 74\u201380","journal-title":"J Autoimmun"},{"issue":"3","key":"386_CR38","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/hep.26583","volume":"59","author":"CR Grant","year":"2014","unstructured":"Grant CR, Liberal R, Holder BS, Cardone J, Ma Y, Robson SC, Mieli-Vergani G, Vergani D, Longhi MS. Dysfunctional CD39 (POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis. Hepatology 2014; 59(3): 1007\u20131015","journal-title":"Hepatology"},{"issue":"1","key":"386_CR39","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jhep.2012.02.029","volume":"57","author":"M Peiseler","year":"2012","unstructured":"Peiseler M, Sebode M, Franke B, Wortmann F, Schwinge D, Quaas A, Baron U, Olek S, Wiegard C, Lohse AW, Weiler-Normann C, Schramm C, Herkel J. FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency. J Hepatol 2012; 57(1): 125\u2013132","journal-title":"J Hepatol"},{"issue":"2","key":"386_CR40","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/hep.24153","volume":"53","author":"JM Vierling","year":"2011","unstructured":"Vierling JM. Autoimmune hepatitis and antigen-specific T regulatory cells: when can we send in the regulators? Hepatology 2011; 53(2): 385\u2013388","journal-title":"Hepatology"},{"issue":"2","key":"386_CR41","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/hep.24080","volume":"53","author":"RT Stravitz","year":"2011","unstructured":"Stravitz RT, Lefkowitch JH, Fontana RJ, Gershwin ME, Leung PS, Sterling RK, Manns MP, Norman GL, Lee WM. Autoimmune acute liver failure: proposed clinical and histological criteria. Hepatology 2011; 53(2): 517\u2013526","journal-title":"Hepatology"},{"issue":"6","key":"386_CR42","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/hepr.12031","volume":"43","author":"A Tanaka","year":"2013","unstructured":"Tanaka A. Acute presentation of autoimmune hepatitis: how to find and manage still remains unsolved. Hepatol Res 2013; 43(6): 577\u2013579","journal-title":"Hepatol Res"},{"issue":"4","key":"386_CR43","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s10620-012-2445-4","volume":"58","author":"AJ Czaja","year":"2013","unstructured":"Czaja AJ. Acute and acute severe (fulminant) autoimmune hepatitis. Dig Dis Sci 2013; 58(4): 897\u2013914","journal-title":"Dig Dis Sci"},{"issue":"4","key":"386_CR44","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0016-5085(78)90238-X","volume":"74","author":"J Scott","year":"1978","unstructured":"Scott J, Gollan JL, Samourian S, Sherlock S. Wilson\u2019s disease, presenting as chronic active hepatitis. Gastroenterology 1978; 74(4): 645\u2013651","journal-title":"Gastroenterology"},{"issue":"5","key":"386_CR45","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1046\/j.1440-1746.2000.02158.x","volume":"15","author":"P Milkiewicz","year":"2000","unstructured":"Milkiewicz P, Saksena S, Hubscher SG, Elias E. Wilson\u2019s disease with superimposed autoimmune features: report of two cases and review. J Gastroenterol Hepatol 2000; 15(5): 570\u2013574","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"386_CR46","doi-asserted-by":"crossref","first-page":"e7872","DOI":"10.5812\/hepatmon.7872","volume":"13","author":"M Deutsch","year":"2013","unstructured":"Deutsch M, Emmanuel T, Koskinas J. Autoimmune hepatitis or Wilson\u2019s disease, a clinical dilemma. Hepat Mon 2013; 13(5): e7872","journal-title":"Hepat Mon"},{"issue":"1","key":"386_CR47","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1399-3046.2005.00254.x","volume":"9","author":"RG Santos","year":"2005","unstructured":"Santos RG, Alissa F, Reyes J, Teot L, Ameen N. Fulminant hepatic failure:Wilson\u2019s disease or autoimmune hepatitis? Implications for transplantation. Pediatr Transplant 2005; 9(1): 112\u2013116","journal-title":"Pediatr Transplant"},{"issue":"3","key":"386_CR48","first-page":"123","volume":"15","author":"S Kaymako\u011flu","year":"2004","unstructured":"Kaymako\u011flu S. Drug-induced hepatitis, drug-induced autoimmunity or classical autoimmune hepatitis: how can we differentiate? Turk J Gastroenterol 2004; 15(3): 123\u2013125","journal-title":"Turk J Gastroenterol"},{"issue":"2","key":"386_CR49","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/hep.24768","volume":"55","author":"K Fujiwara","year":"2012","unstructured":"Fujiwara K, Yokosuka O. Histological discrimination between autoimmune hepatitis and drug-induced liver injury. Hepatology 2012; 55(2): 657","journal-title":"Hepatology"},{"issue":"5","key":"386_CR50","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WG, Czaja AJ, Desmet VJ, Donaldson PT, Eddleston AL, Fainboim L, Heathcote J, Homberg JC, Hoofnagle JH, Kakumu S, Krawitt EL, Mackay IR, MacSween RN, Maddrey WC, Manns MP, McFarlane IG, Meyer zum B\u00fcschenfelde KH, Zeniya M, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31(5): 929\u2013938","journal-title":"J Hepatol"},{"issue":"1","key":"386_CR51","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","volume":"48","author":"EM Hennes","year":"2008","unstructured":"Hennes EM, Zeniya M, Czaja AJ, Par\u00e9s A, Dalekos GN, Krawitt EL, Bittencourt PL, Porta G, Boberg KM, Hofer H, Bianchi FB, Shibata M, Schramm C, Eisenmann de Torres B, Galle PR, McFarlane I, Dienes HP, Lohse AW. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008; 48(1): 169\u2013176","journal-title":"Hepatology"},{"issue":"4\u20135","key":"386_CR52","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.autrev.2013.11.009","volume":"13","author":"R Liberal","year":"2014","unstructured":"Liberal R, Grant CR, Longhi MS, Mieli-Vergani G, Vergani D. Diagnostic criteria of autoimmune hepatitis. Autoimmun Rev 2014; 13(4\u20135): 435\u2013440","journal-title":"Autoimmun Rev"},{"issue":"11","key":"386_CR53","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.dld.2010.03.005","volume":"42","author":"NK Gatselis","year":"2010","unstructured":"Gatselis NK, Zachou K, Papamichalis P, Koukoulis GK, Gabeta S, Dalekos GN, Rigopoulou EI. Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: a new or a complementary diagnostic score? Dig Liver Dis 2010; 42(11): 807\u2013812","journal-title":"Dig Liver Dis"},{"issue":"5","key":"386_CR54","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1053\/j.gastro.2011.02.010","volume":"140","author":"AJ Czaja","year":"2011","unstructured":"Czaja AJ. Comparability of probable and definite autoimmune hepatitis by international diagnostic scoring criteria. Gastroenterology 2011; 140(5): 1472\u20131480","journal-title":"Gastroenterology"},{"issue":"23","key":"386_CR55","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.3748\/wjg.v19.i23.3629","volume":"19","author":"MR Abdollahi","year":"2013","unstructured":"Abdollahi MR, Somi MH, Faraji E. Role of international criteria in the diagnosis of autoimmune hepatitis. World J Gastroenterol 2013; 19(23): 3629\u20133633","journal-title":"World J Gastroenterol"},{"issue":"1","key":"386_CR56","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3892\/etm.2013.1366","volume":"7","author":"Y Li","year":"2014","unstructured":"Li Y, Peng M, Gong G. Evaluation of the revised versus the simplified scoring system in patients with autoimmune hepatitis. Exp Ther Med 2014; 7(1): 131\u2013136","journal-title":"Exp Ther Med"},{"issue":"2","key":"386_CR57","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jhep.2010.06.032","volume":"54","author":"D Qiu","year":"2011","unstructured":"Qiu D, Wang Q, Wang H, Xie Q, Zang G, Jiang H, Tu C, Guo J, Zhang S, Wang J, Lu Y, Han Y, Shen L, Chen X, Hu X, Wang X, Chen C, Fu Q, Ma X. Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients. J Hepatol 2011; 54(2): 340\u2013347","journal-title":"J Hepatol"},{"issue":"2","key":"386_CR58","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jhep.2010.07.013","volume":"54","author":"AW Lohse","year":"2011","unstructured":"Lohse AW. Recognizing autoimmune hepatitis: scores help, but no more. J Hepatol 2011; 54(2): 193\u2013194","journal-title":"J Hepatol"},{"issue":"4","key":"386_CR59","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/1751-2980.12022","volume":"14","author":"QX Wang","year":"2013","unstructured":"Wang QX, Jiang WJ, Miao Q, Xiao X, Zhang HY, Huang SS, Shen L, Hua J, Li H, Li S, Qiu K, Ma X. Clinical and histological features of autoantibody-negative autoimmune hepatitis in Chinese patients: a single center experience. J Dig Dis 2013; 14(4): 175\u2013180","journal-title":"J Dig Dis"},{"issue":"2","key":"386_CR60","first-page":"326","volume":"58","author":"AJ Czaja","year":"2013","unstructured":"Czaja AJ. The overlap syndromes of autoimmune hepatitis. Dig Dis Sci 2013; 58(2): 326\u2013343","journal-title":"Dig Dis Sci"},{"issue":"2","key":"386_CR61","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","volume":"54","author":"KM Boberg","year":"2011","unstructured":"Boberg KM, Chapman RW, Hirschfield GM, Lohse AW, Manns MP, Schrumpf E. Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol 2011; 54(2): 374\u2013385","journal-title":"J Hepatol"},{"issue":"S1","key":"386_CR62","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00535-010-0324-3","volume":"46","author":"EL Krawitt","year":"2011","unstructured":"Krawitt EL. Discrimination of autoimmune hepatitis: autoantibody typing and beyond. J Gastroenterol 2011; 46(S1): 39\u201341","journal-title":"J Gastroenterol"},{"issue":"2","key":"386_CR63","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/hep.26666","volume":"59","author":"CA Couto","year":"2014","unstructured":"Couto CA, Bittencourt PL, Porta G, Abrantes-Lemos CP, Carrilho FJ, Guardia BD, Can\u00e7ado EL. Antismooth muscle and antiactin antibodies are indirect markers of histological and biochemical activity of autoimmune hepatitis. Hepatology 2014; 59(2): 592\u2013600","journal-title":"Hepatology"},{"issue":"3","key":"386_CR64","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s10620-011-2017-z","volume":"57","author":"AJ Czaja","year":"2012","unstructured":"Czaja AJ. Autoantibody-negative autoimmune hepatitis. Dig Dis Sci 2012; 57(3): 610\u2013624","journal-title":"Dig Dis Sci"},{"issue":"2","key":"386_CR65","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10620-010-1501-1","volume":"56","author":"AJ Czaja","year":"2011","unstructured":"Czaja AJ. Performance parameters of the conventional serological markers for autoimmune hepatitis. Dig Dis Sci 2011; 56(2): 545\u2013554","journal-title":"Dig Dis Sci"},{"issue":"4","key":"386_CR66","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","volume":"41","author":"D Vergani","year":"2004","unstructured":"Vergani D, Alvarez F, Bianchi FB, Can\u00e7ado EL, Mackay IR, Manns MP, Nishioka M, Penner E. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol 2004; 41(4): 677\u2013683","journal-title":"J Hepatol"},{"issue":"4","key":"386_CR67","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jaut.2010.09.005","volume":"35","author":"H Liu","year":"2010","unstructured":"Liu H, Norman GL, Shums Z, Worman HJ, Krawitt EL, Bizzaro N, Vergani D, Bogdanos DP, Dalekos GN, Milkiewicz P, Czaja AJ, Heathcote EJ, Hirschfield GM, Tan EM, Miyachi K, Bignotto M, Battezzati PM, Lleo A, Leung PS, Podda M, Gershwin ME, Invernizzi P. PBC screen: an IgG\/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun 2010; 35(4): 436\u2013442","journal-title":"J Autoimmun"},{"issue":"8","key":"386_CR68","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1007\/s10620-010-1268-4","volume":"55","author":"AJ Czaja","year":"2010","unstructured":"Czaja AJ. Autoantibodies as prognostic markers in autoimmune liver disease. Dig Dis Sci 2010; 55(8): 2144\u20132161","journal-title":"Dig Dis Sci"},{"issue":"7","key":"386_CR69","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.autrev.2010.12.009","volume":"10","author":"KG Oikonomou","year":"2011","unstructured":"Oikonomou KG, Zachou K, Dalekos GN. Alpha-actinin: a multidisciplinary protein with important role in B-cell driven autoimmunity. Autoimmun Rev 2011; 10(7): 389\u2013396","journal-title":"Autoimmun Rev"},{"issue":"9","key":"386_CR70","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/hepr.12276","volume":"44","author":"Y Kanno","year":"2014","unstructured":"Kanno Y, Watanabe H, Takahashi A, Abe K, Ohira H. Antiphosphoenolpyruvate carboxykinase 2 antibody in patients with autoimmune hepatitis. Hepatol Res 2014; 44(9): 1019\u20131025","journal-title":"Hepatol Res"},{"issue":"6","key":"386_CR71","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/liv.12155","volume":"33","author":"AL Calich","year":"2013","unstructured":"Calich AL, Viana VS, Cancado E, Tustumi F, Terrabuio DR, Leon EP, Silva CA, Borba EF, Bonfa E. Anti-ribosomal P protein: a novel antibody in autoimmune hepatitis. Liver Int 2013; 33(6): 909\u2013913","journal-title":"Liver Int"},{"key":"386_CR72","volume-title":"Hepatol Res","author":"J Yokokawa","year":"2013","unstructured":"Yokokawa J, Kanno Y, Abe K, Saito H, Monoe K, Katsushima F, Sakamoto N, Takahashi A, Yokokawa H, Ohira H. Antinucleosome autoantibodies as markers for autoimmune hepatitis and their correlation with disease activity. Hepatol Res 2013 [Epub ahead of print] doi: 10.1111\/hepr.12130"},{"issue":"1","key":"386_CR73","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/jgh.12340","volume":"29","author":"K Matsumoto","year":"2014","unstructured":"Matsumoto K, Miyake Y, Matsushita H, Ohnishi A, Ikeda F, Shiraha H, Takaki A, Nouso K, Yamamoto K. Anti-programmed cell death-1 antibody as a new serological marker for type 1 autoimmune hepatitis. J Gastroenterol Hepatol 2014; 29(1): 110\u2013115","journal-title":"J Gastroenterol Hepatol"},{"issue":"12","key":"386_CR74","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1074\/mcp.M112.018713","volume":"11","author":"C Zingaretti","year":"2012","unstructured":"Zingaretti C, Arig\u00f2 M, Cardaci A, Moro M, Crosti M, Sinisi A, Sugliano E, Cheroni C, Marabita F, Nogarotto R, Bonnal RJ, Marcatili P, Marconi M, Zignego A, Muratori P, Invernizzi P, Colombatto P, Brunetto M, Bonino F, De Francesco R, Geginat J, Pagani M, Muratori L, Abrignani S, Bombaci M. Identification of new autoantigens by protein array indicates a role for IL4 neutralization in autoimmune hepatitis. Mol Cell Proteomics 2012; 11(12): 1885\u20131897","journal-title":"Mol Cell Proteomics"},{"issue":"4","key":"386_CR75","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.cld.2010.07.003","volume":"14","author":"M Guindi","year":"2010","unstructured":"Guindi M. Histology of autoimmune hepatitis and its variants. Clin Liver Dis 2010; 14(4): 577\u2013590","journal-title":"Clin Liver Dis"},{"issue":"4","key":"386_CR76","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3109\/00365521.2013.772231","volume":"48","author":"C Efe","year":"2013","unstructured":"Efe C, Wahlin S, Ozaslan E, Purnak T, Muratori L, Quarneti C, Tatar G, Simsek H, Muratori P, Schiano TD. Diagnostic difficulties, therapeutic strategies, and performance of scoring systems in patients with autoimmune hepatitis and concurrent hepatitis B\/C. Scand J Gastroenterol 2013; 48(4): 504\u2013508","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"386_CR77","doi-asserted-by":"crossref","first-page":"e85330","DOI":"10.1371\/journal.pone.0085330","volume":"9","author":"S Pischke","year":"2014","unstructured":"Pischke S, Gisa A, Suneetha PV, Wiegand SB, Taubert R, Schlue J, Wursthorn K, Bantel H, Raupach R, Bremer B, Zacher BJ, Schmidt RE, Manns MP, Rifai K, Witte T, Wedemeyer H. Increased HEV seroprevalence in patients with autoimmune hepatitis. PLoS ONE 2014; 9(1): e85330","journal-title":"PLoS ONE"},{"issue":"2","key":"386_CR78","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/gut.41.2.269","volume":"41","author":"HS Te","year":"1997","unstructured":"Te HS, Koukoulis G, Ganger DR. Autoimmune hepatitis: a histological variant associated with prominent centrilobular necrosis. Gut 1997; 41(2): 269\u2013271","journal-title":"Gut"},{"issue":"3","key":"386_CR79","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/jcp.2005.029348","volume":"59","author":"H Hofer","year":"2006","unstructured":"Hofer H, Oesterreicher C, Wrba F, Ferenci P, Penner E. Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation. J Clin Pathol 2006; 59(3): 246\u2013249","journal-title":"J Clin Pathol"},{"issue":"1","key":"386_CR80","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cgh.2010.07.016","volume":"9","author":"E Bj\u00f6rnsson","year":"2011","unstructured":"Bj\u00f6rnsson E, Talwalkar J, Treeprasertsuk S, Neuhauser M, Lindor K. Patients with typical laboratory features of autoimmune hepatitis rarely need a liver biopsy for diagnosis. Clin Gastroenterol Hepatol 2011; 9(1): 57\u201363","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"386_CR81","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s00535-010-0316-3","volume":"46","author":"S Yasui","year":"2011","unstructured":"Yasui S, Fujiwara K, Yonemitsu Y, Oda S, Nakano M, Yokosuka O. Clinicopathological features of severe and fulminant forms of autoimmune hepatitis. J Gastroenterol 2011; 46(3): 378\u2013390","journal-title":"J Gastroenterol"},{"issue":"7","key":"386_CR82","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/lt.21088","volume":"13","author":"AJ Czaja","year":"2007","unstructured":"Czaja AJ. Corticosteroids or not in severe acute or fulminant autoimmune hepatitis: therapeutic brinksmanship and the point beyond salvation. Liver Transpl 2007; 13(7): 953\u2013955","journal-title":"Liver Transpl"},{"issue":"7","key":"386_CR83","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/lt.21036","volume":"13","author":"P Ichai","year":"2007","unstructured":"Ichai P, Duclos-Vall\u00e9e JC, Guettier C, Hamida SB, Antonini T, Delvart V, Saliba F, Azoulay D, Castaing D, Samuel D. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis. Liver Transpl 2007; 13(7): 996\u20131003","journal-title":"Liver Transpl"},{"issue":"7","key":"386_CR84","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1542-3565(04)00246-0","volume":"2","author":"WR Kessler","year":"2004","unstructured":"Kessler WR, Cummings OW, Eckert G, Chalasani N, Lumeng L, Kwo PY. Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol 2004; 2(7): 625\u2013631","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"386_CR85","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/hep.22894","volume":"49","author":"S Verma","year":"2009","unstructured":"Verma S, Maheshwari A, Thuluvath P. Liver failure as initial presentation of autoimmune hepatitis: clinical characteristics, predictors of response to steroid therapy, and outcomes. Hepatology 2009; 49(4): 1396\u20131397","journal-title":"Hepatology"},{"key":"386_CR86","unstructured":"Villamil AG, Casciato P, Eduardo M, et al. Fulminant autoimmune hepatitis type 1: clinical presentation, outcome and prognostic factors(Abstract 480). AJT 5(suppl 11): 2011"},{"issue":"8","key":"386_CR87","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1007\/s10620-009-0996-9","volume":"55","author":"C Efe","year":"2010","unstructured":"Efe C, Ozaslan E, Nasiroglu N, Tunca H, Purnak T, Altiparmak E. The development of autoimmune hepatitis and primary biliary cirrhosis overlap syndrome during the course of connective tissue diseases: report of three cases and review of the literature. Dig Dis Sci 2010; 55(8): 2417\u20132421","journal-title":"Dig Dis Sci"},{"issue":"11","key":"386_CR88","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1023\/B:DDAS.0000004522.36120.08","volume":"48","author":"P Loria","year":"2003","unstructured":"Loria P, Lonardo A, Leonardi F, Fontana C, Carulli L, Verrone AM, Borsatti A, Bertolotti M, Cassani F, Bagni A, Muratori P, Ganazzi D, Bianchi FB, Carulli N. Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates. Dig Dis Sci 2003; 48(11): 2173\u20132181","journal-title":"Dig Dis Sci"},{"issue":"9","key":"386_CR89","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/01.mcg.0000139072.38580.a0","volume":"38","author":"SJ Cotler","year":"2004","unstructured":"Cotler SJ, Kanji K, Keshavarzian A, Jensen DM, Jakate S. Prevalence and significance of autoantibodies in patients with nonalcoholic steatohepatitis. J Clin Gastroenterol 2004; 38(9): 801\u2013804","journal-title":"J Clin Gastroenterol"},{"issue":"29","key":"386_CR90","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.3748\/wjg.v16.i29.3704","volume":"16","author":"RG Badiani","year":"2010","unstructured":"Badiani RG, Becker V, Perez RM, Matos CA, Lemos LB, Lanzoni VP, Andrade LE, Dellavance A, Silva AE, Ferraz ML. Is autoimmune hepatitis a frequent finding among HCV patients with intense interface hepatitis? World J Gastroenterol 2010; 16(29): 3704\u20133708","journal-title":"World J Gastroenterol"},{"issue":"9","key":"386_CR91","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.dld.2010.01.022","volume":"42","author":"A Zellos","year":"2010","unstructured":"Zellos A, Boitnott JK, Schwarz KB. New-onset autoimmune hepatitis in young patients with preexisting liver disease. Dig Liver Dis 2010; 42(9): 657\u2013660","journal-title":"Dig Liver Dis"},{"issue":"1","key":"386_CR92","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/lt.23764","volume":"20","author":"A Unzueta","year":"2014","unstructured":"Unzueta A, Rakela J. Hepatitis E infection in liver transplant recipients. Liver Transpl 2014; 20(1): 15\u201324","journal-title":"Liver Transpl"},{"issue":"3","key":"386_CR93","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/jmv.23469","volume":"85","author":"V Moal","year":"2013","unstructured":"Moal V, Legris T, Burtey S, Morange S, Purgus R, Dussol B, Garcia S, Motte A, G\u00e9rolami R, Berland Y, Colson P. Infection with hepatitis E virus in kidney transplant recipients in southeastern France. J Med Virol 2013; 85(3): 462\u2013471","journal-title":"J Med Virol"},{"issue":"3","key":"386_CR94","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","volume":"53","author":"J Bruix","year":"2011","unstructured":"Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53(3): 1020\u20131022","journal-title":"Hepatology"},{"issue":"3","key":"386_CR95","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/hep.25869","volume":"56","author":"M Sherman","year":"2012","unstructured":"Sherman M, Bruix J, Porayko M, Tran T. Screening for hepatocellular carcinoma: the rationale for the American Association for the Study of Liver Diseases recommendations. Hepatology 2012; 56(3): 793\u2013796","journal-title":"Hepatology"},{"issue":"6","key":"386_CR96","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s10620-012-2525-5","volume":"58","author":"AJ Czaja","year":"2013","unstructured":"Czaja AJ. Hepatocellular carcinoma and other malignancies in autoimmune hepatitis. Dig Dis Sci 2013; 58(6): 1459\u20131476","journal-title":"Dig Dis Sci"},{"issue":"1","key":"386_CR97","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00535-012-0616-x","volume":"48","author":"H Ohira","year":"2013","unstructured":"Ohira H, Abe K, Takahashi A, Zeniya M, Ichida T. Clinical features of hepatocellular carcinoma in patients with autoimmune hepatitis in Japan. J Gastroenterol 2013; 48(1): 109\u2013114","journal-title":"J Gastroenterol"},{"issue":"3","key":"386_CR98","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/hep.22432","volume":"48","author":"AD Yeoman","year":"2008","unstructured":"Yeoman AD, Al-Chalabi T, Karani JB, Quaglia A, Devlin J, Mieli-Vergani G, Bomford A, O\u2019Grady JG, Harrison PM, Heneghan MA. Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: implications for follow-up and screening. Hepatology 2008; 48(3): 863\u2013870","journal-title":"Hepatology"},{"issue":"9","key":"386_CR99","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.cgh.2013.08.039","volume":"12","author":"AJ Czaja","year":"2014","unstructured":"Czaja AJ. Cholestatic phenotypes of autoimmune hepatitis. Clin Gastroenterol Hepatol 2014; 12(9): 1430\u20131438","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"386_CR100","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1155\/2013\/198070","volume":"27","author":"AJ Czaja","year":"2013","unstructured":"Czaja AJ. Diagnosis and management of the overlap syndromes of autoimmune hepatitis. Can J Gastroenterol 2013; 27(7): 417\u2013423","journal-title":"Can J Gastroenterol"},{"issue":"8","key":"386_CR101","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/j.1478-3231.2007.01538.x","volume":"27","author":"AA Gossard","year":"2007","unstructured":"Gossard AA, Lindor KD. Development of autoimmune hepatitis in primary biliary cirrhosis. Liver Int 2007; 27(8): 1086\u20131090","journal-title":"Liver Int"},{"issue":"2","key":"386_CR102","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jhep.2005.11.037","volume":"44","author":"AJ Czaja","year":"2006","unstructured":"Czaja AJ. Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a foray across diagnostic boundaries. J Hepatol 2006; 44(2): 251\u2013252","journal-title":"J Hepatol"},{"issue":"2","key":"386_CR103","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ajg.2009.616","volume":"105","author":"M Neuhauser","year":"2010","unstructured":"Neuhauser M, Bjornsson E, Treeprasertsuk S, Enders F, Silveira M, Talwalkar J, Lindor K. Autoimmune hepatitis-PBC overlap syndrome: a simplified scoring system may assist in the diagnosis. Am J Gastroenterol 2010; 105(2): 345\u2013353","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"386_CR104","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","volume":"28","author":"O Chazouill\u00e8res","year":"1998","unstructured":"Chazouill\u00e8res O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 1998; 28(2): 296\u2013301","journal-title":"Hepatology"},{"issue":"6","key":"386_CR105","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.cgh.2010.03.004","volume":"8","author":"EM Kuiper","year":"2010","unstructured":"Kuiper EM, Zondervan PE, van Buuren HR. Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome. Clin Gastroenterol Hepatol 2010; 8(6): 530\u2013534","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"386_CR106","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1440-1746.2009.06018.x","volume":"25","author":"J Yokokawa","year":"2010","unstructured":"Yokokawa J, Saito H, Kanno Y, Honma F, Monoe K, Sakamoto N, Abe K, Takahashi A, Yokokawa H, Ohira H. Overlap of primary biliary cirrhosis and autoimmune hepatitis: characteristics, therapy, and long term outcomes. J Gastroenterol Hepatol 2010; 25(2): 376\u2013382","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"386_CR107","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0399-8320(07)89323-7","volume":"31","author":"A Heurgu\u00e9","year":"2007","unstructured":"Heurgu\u00e9 A, Vitry F, Diebold MD, Yaziji N, Bernard-Chabert B, Pennaforte JL, Picot R, Louvet H, Fr\u00e9mond L, Geoffroy P, Schmit JL, Cadiot G, Thi\u00e9fin G. Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease. Gastroenterol Clin Biol 2007; 31(1): 17\u201325","journal-title":"Gastroenterol Clin Biol"},{"issue":"9","key":"386_CR108","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/hepr.12210","volume":"44","author":"Y Yoshioka","year":"2014","unstructured":"Yoshioka Y, Taniai M, Hashimoto E, Haruta I, Shiratori K. Clinical profile of primary biliary cirrhosis with features of autoimmune hepatitis: importance of corticosteroid therapy. Hepatol Res 2014; 44(9): 947\u2013955","journal-title":"Hepatol Res"},{"issue":"99\u2013100","key":"386_CR109","first-page":"441","volume":"57","author":"E Ozaslan","year":"2010","unstructured":"Ozaslan E, Efe C, Akbulut S, Purnak T, Savas B, Erden E, Altiparmak E. Therapy response and outcome of overlap syndromes: autoimmune hepatitis and primary biliary cirrhosis compared to autoimmune hepatitis and autoimmune cholangitis. Hepatogastroenterology 2010; 57(99\u2013100): 441\u2013446","journal-title":"Hepatogastroenterology"},{"issue":"6","key":"386_CR110","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1572-0241.2007.01136.x","volume":"102","author":"MG Silveira","year":"2007","unstructured":"Silveira MG, Talwalkar JA, Angulo P, Lindor KD. Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes. Am J Gastroenterol 2007; 102(6): 1244\u20131250","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"386_CR111","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/MEG.0b013e328350f95b","volume":"24","author":"C Efe","year":"2012","unstructured":"Efe C, Wahlin S, Ozaslan E, Berlot AH, Purnak T, Muratori L, Quarneti C, Y\u00fcksel O, Thi\u00e9fin G, Muratori P. Autoimmune hepatitis\/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases. Eur J Gastroenterol Hepatol 2012; 24(5): 531\u2013534","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"386_CR112","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1665-2681(19)31583-2","volume":"10","author":"E Coss Adame","year":"2011","unstructured":"Coss Adame E, Granados J, Uribe M, Torre A. Does HLA-DR7 differentiate the overlap syndrome of auto-immune hepatitisprimary biliary cirrhosis (AIH-PBC) from those with auto-immune hepatitis type 1? Ann Hepatol 2011; 10(1): 28\u201332","journal-title":"Ann Hepatol"},{"issue":"8","key":"386_CR113","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.cgh.2013.12.010","volume":"12","author":"C Levy","year":"2014","unstructured":"Levy C, Naik J, Giordano C, Mandalia A, O\u2019Brien C, Bhamidimarri KR, Schiff ER, Martin P. Hispanics with primary biliary cirrhosis are more likely to have features of autoimmune hepatitis and reduced response to ursodeoxycholic acid than non-Hispanics. Clin Gastroenterol Hepatol 2014; 12(8): 1398\u20131405","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"386_CR114","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1309\/AJCPE93GZSHUNTAI","volume":"133","author":"H Lee","year":"2010","unstructured":"Lee H, Stapp RT, Ormsby AH, Shah VV. The usefulness of IgG and IgM immunostaining of periportal inflammatory cells (plasma cells and lymphocytes) for the distinction of autoimmune hepatitis and primary biliary cirrhosis and their staining pattern in autoimmune hepatitis-primary biliary cirrhosis overlap syndrome. Am J Clin Pathol 2010; 133(3): 430\u2013437","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"386_CR115","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.dld.2009.12.006","volume":"42","author":"D Cabibi","year":"2010","unstructured":"Cabibi D, Tarantino G, Barbaria F, Campione M, Crax\u00cc A, Di Marco V. Intrahepatic IgG\/IgM plasma cells ratio helps in classifying autoimmune liver diseases. Dig Liver Dis 2010; 42(8): 585\u2013592","journal-title":"Dig Liver Dis"},{"issue":"4","key":"386_CR116","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0168-8278(00)80004-5","volume":"33","author":"M Kaya","year":"2000","unstructured":"Kaya M, Angulo P, Lindor KD. Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system. J Hepatol 2000; 33(4): 537\u2013542","journal-title":"J Hepatol"},{"issue":"1","key":"386_CR117","first-page":"15","volume":"80","author":"M Hunter","year":"2011","unstructured":"Hunter M, Loughrey MB, Gray M, Ellis P, McDougall N, Callender M. Evaluating distinctive features for early diagnosis of primary sclerosing cholangitis overlap syndrome in adults with autoimmune hepatitis. Ulster Med J 2011; 80(1): 15\u201318","journal-title":"Ulster Med J"},{"issue":"7","key":"386_CR118","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1572-0241.2005.41841.x","volume":"100","author":"A Floreani","year":"2005","unstructured":"Floreani A, Rizzotto ER, Ferrara F, Carderi I, Caroli D, Blasone L, Baldo V. Clinical course and outcome of autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome. Am J Gastroenterol 2005; 100(7): 1516\u20131522","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"386_CR119","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11894-999-0089-0","volume":"1","author":"AJ Czaja","year":"1999","unstructured":"Czaja AJ. Variant forms of autoimmune hepatitis. Curr Gastroenterol Rep 1999; 1(1): 63\u201370","journal-title":"Curr Gastroenterol Rep"},{"issue":"4","key":"386_CR120","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/apt.12381","volume":"38","author":"AJ Czaja","year":"2013","unstructured":"Czaja AJ. Review article: the management of autoimmune hepatitis beyond consensus guidelines. Aliment Pharmacol Ther 2013; 38(4): 343\u2013364","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"386_CR121","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1365-2036.2011.04658.x","volume":"33","author":"EL Culver","year":"2011","unstructured":"Culver EL, Chapman RW. Systematic review: management options for primary sclerosing cholangitis and its variant forms-IgG4-associated cholangitis and overlap with autoimmune hepatitis. Aliment Pharmacol Ther 2011; 33(12): 1273\u20131291","journal-title":"Aliment Pharmacol Ther"},{"issue":"S1Suppl1","key":"386_CR122","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00535-010-0323-4","volume":"46","author":"T Umemura","year":"2011","unstructured":"Umemura T, Zen Y, Hamano H, Joshita S, Ichijo T, Yoshizawa K, Kiyosawa K, Ota M, Kawa S, Nakanuma Y, Tanaka E. Clinical significance of immunoglobulin G4-associated autoimmune hepatitis. J Gastroenterol 2011; 46(S1 Suppl 1): 48\u201355","journal-title":"J Gastroenterol"},{"issue":"10","key":"386_CR123","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1345\/aph.1H136","volume":"40","author":"MC Peedikayil","year":"2006","unstructured":"Peedikayil MC, Dahhan TI, Al Ashgar HI. Nitrofurantoin-induced fulminant hepatitis mimicking autoimmune hepatitis. Ann Pharmacother 2006; 40(10): 1888\u20131889","journal-title":"Ann Pharmacother"},{"issue":"8","key":"386_CR124","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/00004836-200609000-00018","volume":"40","author":"V Alla","year":"2006","unstructured":"Alla V, Abraham J, Siddiqui J, Raina D, Wu GY, Chalasani NP, Bonkovsky HL. Autoimmune hepatitis triggered by statins. J Clin Gastroenterol 2006; 40(8): 757\u2013761","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"386_CR125","doi-asserted-by":"crossref","first-page":"219","DOI":"10.5414\/CP201835","volume":"51","author":"J Felden von","year":"2013","unstructured":"von Felden J, Montani M, Kessebohm K, Stickel F. Drug-induced acute liver injury mimicking autoimmune hepatitis after intake of dietary supplements containing glucosamine and chondroitin sulfate. Int J Clin Pharmacol Ther 2013; 51(3): 219\u2013223","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"3","key":"386_CR126","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3350\/cmh.2013.19.3.305","volume":"19","author":"HJ Oh","year":"2013","unstructured":"Oh HJ, Mok YM, Baek MS, Lee JK, Seo BS, Kim TH, Choi KH, Hwang IK, Ra JE, Oh YR, Kim YS, Cho EY, Kim HC, Sohn YW. Co-development of autoimmune hepatitis and Sj\u00f6gren\u2019s syndrome triggered by the administration of herbal medicines. Clin Mol Hepatol 2013; 19(3): 305\u2013308","journal-title":"Clin Mol Hepatol"},{"issue":"6","key":"386_CR127","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/clpt.2011.58","volume":"89","author":"GP Aithal","year":"2011","unstructured":"Aithal GP, Watkins PB, Andrade RJ, Larrey D, Molokhia M, Takikawa H, Hunt CM, Wilke RA, Avigan M, Kaplowitz N, Bjornsson E, Daly AK. Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther 2011; 89(6): 806\u2013815","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"386_CR128","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/hep.24141","volume":"53","author":"AD Yeoman","year":"2011","unstructured":"Yeoman AD, Westbrook RH, Zen Y, Maninchedda P, Portmann BC, Devlin J, O\u2019Grady JG, Harrison PM, Heneghan MA. Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis. Hepatology 2011; 53(3): 926\u2013934","journal-title":"Hepatology"},{"issue":"5","key":"386_CR129","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1002\/hep.23924","volume":"52","author":"L Muratori","year":"2010","unstructured":"Muratori L, Muratori P, Lanzoni G, Ferri S, Lenzi M. Application of the 2010 American Association for the study of liver diseases criteria of remission to a cohort of Italian patients with autoimmune hepatitis. Hepatology 2010; 52(5): 1857\u20131858, author reply 1857\u20131858","journal-title":"Hepatology"},{"issue":"4","key":"386_CR130","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","volume":"139","author":"MP Manns","year":"2010","unstructured":"Manns MP, Woynarowski M, Kreisel W, Lurie Y, Rust C, Zuckerman E, Bahr MJ, G\u00fcnther R, Hultcrantz RW, Spengler U, Lohse AW, Szalay F, F\u00e4rkkil\u00e4 M, Pr\u00f6ls M, Strassburg CP. Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis. Gastroenterology 2010; 139(4): 1198\u20131206","journal-title":"Gastroenterology"},{"issue":"1","key":"386_CR131","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jhep.2010.01.037","volume":"53","author":"MM Lamers","year":"2010","unstructured":"Lamers MM, van Oijen MG, Pronk M, Drenth JP. Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials. J Hepatol 2010; 53(1): 191\u2013198","journal-title":"J Hepatol"},{"issue":"5","key":"386_CR132","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1586\/egh.12.40","volume":"6","author":"AJ Czaja","year":"2012","unstructured":"Czaja AJ. Drug choices in autoimmune hepatitis: part A-steroids. Expert Rev Gastroenterol Hepatol 2012; 6(5): 603\u2013615","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"386_CR133","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000282071","volume":"28","author":"CP Strassburg","year":"2010","unstructured":"Strassburg CP. Therapeutic options to treat autoimmune hepatitis in 2009. Dig Dis 2010; 28(1): 93\u201398","journal-title":"Dig Dis"},{"issue":"12","key":"386_CR134","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.3748\/wjg.v9.i12.2681","volume":"9","author":"A Geier","year":"2003","unstructured":"Geier A, Gartung C, Dietrich CG, Wasmuth HE, Reinartz P, Matern S. Side effects of budesonide in liver cirrhosis due to chronic autoimmune hepatitis: influence of hepatic metabolism versus portosystemic shunts on a patient complicated with HCC. World J Gastroenterol 2003; 9(12): 2681\u20132685","journal-title":"World J Gastroenterol"},{"issue":"4","key":"386_CR135","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jhep.2010.09.017","volume":"54","author":"AW Lohse","year":"2011","unstructured":"Lohse AW, Gil H. Reactivation of autoimmune hepatitis during budesonide monotherapy, and response to standard treatment. J Hepatol 2011; 54(4): 837\u2013839","journal-title":"J Hepatol"},{"issue":"1","key":"386_CR136","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jhep.2012.09.009","volume":"58","author":"NM Gerven van","year":"2013","unstructured":"van Gerven NM, Verwer BJ, Witte BI, van Hoek B, Coenraad MJ, van Erpecum KJ, Beuers U, van Buuren HR, de Man RA, Drenth JP, den Ouden JW, Verdonk RC, Koek GH, Brouwer JT, Guichelaar MM, Mulder CJ, van Nieuwkerk KM, Bouma G. Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission. J Hepatol 2013; 58(1): 141\u2013147","journal-title":"J Hepatol"},{"issue":"10","key":"386_CR137","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/apt.12701","volume":"39","author":"AJ Czaja","year":"2014","unstructured":"Czaja AJ. Review article: permanent drug withdrawal is desirable and achievable for autoimmune hepatitis. Aliment Pharmacol Ther 2014; 39(10): 1043\u20131058","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"386_CR138","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1478-3231.2007.01444.x","volume":"27","author":"AJ Montano-Loza","year":"2007","unstructured":"Montano-Loza AJ, Carpenter HA, Czaja AJ. Consequences of treatment withdrawal in type 1 autoimmune hepatitis. Liver Int 2007; 27(4): 507\u2013515","journal-title":"Liver Int"},{"issue":"5","key":"386_CR139","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s10620-006-9336-5","volume":"51","author":"AJ Czaja","year":"2006","unstructured":"Czaja AJ, Carpenter HA. Thiopurine methyltransferase deficiency and azathioprine intolerance in autoimmune hepatitis. Dig Dis Sci 2006; 51(5): 968\u2013975","journal-title":"Dig Dis Sci"},{"issue":"5","key":"386_CR140","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1007\/s10620-006-9119-z","volume":"52","author":"JP Gisbert","year":"2007","unstructured":"Gisbert JP, Gomoll\u00f3n F, Cara C, Luna M, Gonz\u00e1lez-Lama Y, Pajares JM, Mat\u00e9 J, Guijarro LG. Thiopurine methyltransferase activity in Spain: a study of 14,545 patients. Dig Dis Sci 2007; 52(5): 1262\u20131269","journal-title":"Dig Dis Sci"},{"issue":"4","key":"386_CR141","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jhep.2006.05.011","volume":"45","author":"MA Heneghan","year":"2006","unstructured":"Heneghan MA, Allan ML, Bornstein JD, Muir AJ, Tendler DA. Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis. J Hepatol 2006; 45(4): 584\u2013591","journal-title":"J Hepatol"},{"issue":"4","key":"386_CR142","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jhep.2006.05.011","volume":"45","author":"MA Heneghan","year":"2006","unstructured":"Heneghan MA, Allan ML, Bornstein JD, Muir AJ, Tendler DA. Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis. J Hepatol 2006; 45(4): 584\u2013591","journal-title":"J Hepatol"},{"issue":"4","key":"386_CR143","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/FTD.0b013e3181dbd712","volume":"32","author":"TM Nguyen","year":"2010","unstructured":"Nguyen TM, Daubard M, Le Gall C, Larger M, Lachaux A, Boulieu R. Monitoring of azathioprine metabolites in pediatric patients with autoimmune hepatitis. Ther Drug Monit 2010; 32(4): 433\u2013437","journal-title":"Ther Drug Monit"},{"issue":"1","key":"386_CR144","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jhep.2009.10.004","volume":"52","author":"U Hindorf","year":"2010","unstructured":"Hindorf U, Jahed K, Bergquist A, Verbaan H, Prytz H, Wallerstedt S, Werner M, Olsson R, Bj\u00f6rnsson E, Peterson C, Almer SH. Characterisation and utility of thiopurine methyltransferase and thiopurine metabolite measurements in autoimmune hepatitis. J Hepatol 2010; 52(1): 106\u2013111","journal-title":"J Hepatol"},{"issue":"6","key":"386_CR145","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/apt.12223","volume":"37","author":"YS Boer de","year":"2013","unstructured":"de Boer YS, van Gerven NM, de Boer NK, Mulder CJ, Bouma G, van Nieuwkerk CM. Allopurinol safely and effectively optimises thiopurine metabolites in patients with autoimmune hepatitis. Aliment Pharmacol Ther 2013; 37(6): 640\u2013646","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"386_CR146","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1155\/2011\/137476","volume":"25","author":"ED Ferucci","year":"2011","unstructured":"Ferucci ED, Hurlburt KJ, Mayo MJ, Livingston S, Deubner H, Gove J, Plotnik J, McMahon BJ. Azathioprine metabolite measurements are not useful in following treatment of autoimmune hepatitis in Alaska Native and other non-Caucasian people. Can J Gastroenterol 2011; 25(1): 21\u201327","journal-title":"Can J Gastroenterol"},{"issue":"4","key":"386_CR147","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1440-1746.2010.06579.x","volume":"26","author":"D Jothimani","year":"2011","unstructured":"Jothimani D, Cramp ME, Mitchell JD, Cross TJ. Treatment of autoimmune hepatitis: a review of current and evolving therapies. J Gastroenterol Hepatol 2011; 26(4): 619\u2013627","journal-title":"J Gastroenterol Hepatol"},{"issue":"98","key":"386_CR148","first-page":"326","volume":"57","author":"SB Wang","year":"2010","unstructured":"Wang SB, Wang JH, Zheng RH, Zhong BH, Chen MH. Deep cholestatic jaundice as the predominant manifestation in autoimmune hepatitis. Hepatogastroenterology 2010; 57(98): 326\u2013329","journal-title":"Hepatogastroenterology"},{"issue":"1","key":"386_CR149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198301063080101","volume":"308","author":"J Roll","year":"1983","unstructured":"Roll J, Boyer JL, Barry D, Klatskin G. The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis. N Engl J Med 1983; 308(1): 1\u20137","journal-title":"N Engl J Med"},{"issue":"5","key":"386_CR150","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/0016-5085(85)90213-6","volume":"89","author":"E Christensen","year":"1985","unstructured":"Christensen E, Neuberger J, Crowe J, Altman DG, Popper H, Portmann B, Doniach D, Ranek L, Tygstrup N, Williams R. Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial. Gastroenterology 1985; 89(5): 1084\u20131091","journal-title":"Gastroenterology"},{"issue":"3","key":"386_CR151","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0168-8278(92)90065-W","volume":"15","author":"HC Mitchison","year":"1992","unstructured":"Mitchison HC, Palmer JM, Bassendine MF, Watson AJ, Record CO, James OF. A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results. J Hepatol 1992; 15(3): 336\u2013344","journal-title":"J Hepatol"},{"issue":"5PT.1","key":"386_CR152","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0016-5085(76)80250-8","volume":"70","author":"J Heathcote","year":"1976","unstructured":"Heathcote J, Ross A, Sherlock S. A prospective controlled trial of azathioprine in primary biliary cirrhosis. Gastroenterology 1976; 70(5 PT.1): 656\u2013660","journal-title":"Gastroenterology"},{"issue":"11","key":"386_CR153","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1007\/s10620-008-0632-0","volume":"54","author":"DC Wolf","year":"2009","unstructured":"Wolf DC, Bojito L, Facciuto M, Lebovics E. Mycophenolate mofetil for autoimmune hepatitis: a single practice experience. Dig Dis Sci 2009; 54(11): 2519\u20132522","journal-title":"Dig Dis Sci"},{"issue":"3","key":"386_CR154","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2036.2011.04727.x","volume":"34","author":"AM Baven-Pronk","year":"2011","unstructured":"Baven-Pronk AM, Coenraad MJ, van Buuren HR, de Man RA, van Erpecum KJ, Lamers MM, Drenth JP, van den Berg AP, Beuers UH, den Ouden J, Koek GH, van Nieuwkerk CM, Bouma G, Brouwer JT, van Hoek B. The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes. Aliment Pharmacol Ther 2011; 34(3): 335\u2013343","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"386_CR155","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1572-0241.2006.00479.x","volume":"101","author":"C Schramm","year":"2006","unstructured":"Schramm C, Herkel J, Beuers U, Kanzler S, Galle PR, Lohse AW. Pregnancy in autoimmune hepatitis: outcome and risk factors. Am J Gastroenterol 2006; 101(3): 556\u2013560","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"386_CR156","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1080\/00365520601155266","volume":"42","author":"M Werner","year":"2007","unstructured":"Werner M, Bj\u00f6rnsson E, Prytz H, Lindgren S, Almer S, Broom\u00e9 U, Wallerstedt S, Sandberg-Gertz\u00e9n H, Hultcrantz R, Sangfeldt P, Nilsson J, Danielsson A. Autoimmune hepatitis among fertile women: strategies during pregnancy and breastfeeding? Scand J Gastroenterol 2007; 42(8): 986\u2013991","journal-title":"Scand J Gastroenterol"},{"issue":"2\u20133","key":"386_CR157","doi-asserted-by":"crossref","first-page":"J239","DOI":"10.1016\/j.jaut.2011.12.002","volume":"38","author":"RH Westbrook","year":"2012","unstructured":"Westbrook RH, Yeoman AD, Kriese S, Heneghan MA. Outcomes of pregnancy in women with autoimmune hepatitis. J Autoimmun 2012; 38(2\u20133): J239\u2013J244","journal-title":"J Autoimmun"},{"issue":"4","key":"386_CR158","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/MCG.0b013e318176b8c5","volume":"43","author":"DR Terrabuio","year":"2009","unstructured":"Terrabuio DR, Abrantes-Lemos CP, Carrilho FJ, Can\u00e7ado EL. Follow-up of pregnant women with autoimmune hepatitis: the disease behavior along with maternal and fetal outcomes. J Clin Gastroenterol 2009; 43(4): 350\u2013356","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"386_CR159","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/j.1572-0241.2006.00538.x","volume":"101","author":"NK Boer de","year":"2006","unstructured":"de Boer NK, Jarbandhan SV, de Graaf P, Mulder CJ, van Elburg RM, van Bodegraven AA. Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites. Am J Gastroenterol 2006; 101(6): 1390\u20131392","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"386_CR160","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S1590-8658(02)80098-6","volume":"34","author":"P Muratori","year":"2002","unstructured":"Muratori P, Loffreda S, Muratori L, Ferrari R, Afandi K, Cassani F, Pappas G, Lenzi M, Bianchi FB. Spontaneous remission of autoimmune hepatitis during pregnancy. Dig Liver Dis 2002; 34(8): 608\u2013609","journal-title":"Dig Liver Dis"},{"issue":"7","key":"386_CR161","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S1542-3565(04)00245-9","volume":"2","author":"D Samuel","year":"2004","unstructured":"Samuel D, Riordan S, Strasser S, Kurtovic J, Singh-Grewel I, Koorey D. Severe autoimmune hepatitis first presenting in the early post partum period. Clin Gastroenterol Hepatol 2004; 2(7): 622\u2013624","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"S1","key":"386_CR162","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000341115","volume":"30","author":"CP Strassburg","year":"2012","unstructured":"Strassburg CP. Autoimmune hepatitis: new guidelines, new therapies. Dig Dis 2012; 30(S1): 11\u201319","journal-title":"Dig Dis"},{"issue":"3","key":"386_CR163","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1586\/egh.09.15","volume":"3","author":"AJ Czaja","year":"2009","unstructured":"Czaja AJ. Current and future treatments of autoimmune hepatitis. Expert Rev Gastroenterol Hepatol 2009; 3(3): 269\u2013291","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"386_CR164","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.gastro.2010.04.053","volume":"139","author":"AJ Czaja","year":"2010","unstructured":"Czaja AJ, Manns MP. Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis. Gastroenterology 2010; 139(1): 58\u201372, e4","journal-title":"Gastroenterology"},{"issue":"8","key":"386_CR165","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3748\/wjg.v16.i8.934","volume":"16","author":"AJ Czaja","year":"2010","unstructured":"Czaja AJ. Difficult treatment decisions in autoimmune hepatitis. World J Gastroenterol 2010; 16(8): 934\u2013947","journal-title":"World J Gastroenterol"},{"issue":"3","key":"386_CR166","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/MOG.0b013e3283457ce0","volume":"27","author":"MJ Mayo","year":"2011","unstructured":"Mayo MJ. Management of autoimmune hepatitis. Curr Opin Gastroenterol 2011; 27(3): 224\u2013230","journal-title":"Curr Opin Gastroenterol"},{"issue":"8","key":"386_CR167","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2036.2010.04241.x","volume":"31","author":"AD Yeoman","year":"2010","unstructured":"Yeoman AD, Longhi MS, Heneghan MA. Review article: the modern management of autoimmune hepatitis. Aliment Pharmacol Ther 2010; 31(8): 771\u2013787","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"386_CR168","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1517\/14656566.2011.524206","volume":"12","author":"D Vergani","year":"2011","unstructured":"Vergani D, Mieli-Vergani G. Pharmacological management of autoimmune hepatitis. Expert Opin Pharmacother 2011; 12(4): 607\u2013613","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"386_CR169","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1586\/egh.12.38","volume":"6","author":"AJ Czaja","year":"2012","unstructured":"Czaja AJ. Drug choices in autoimmune hepatitis: part B-Nonsteroids. Expert Rev Gastroenterol Hepatol 2012; 6(5): 617\u2013635","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"8","key":"386_CR170","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/apt.12042","volume":"36","author":"V Selvarajah","year":"2012","unstructured":"Selvarajah V, Montano-Loza AJ, Czaja AJ. Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs. Aliment Pharmacol Ther 2012; 36(8): 691\u2013707","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"386_CR171","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2174\/187152812803251006","volume":"11","author":"AJ Czaja","year":"2012","unstructured":"Czaja AJ. Nonstandard drugs and feasible new interventions for autoimmune hepatitis: part I. Inflamm Allergy Drug Targets 2012; 11(5): 337\u2013350","journal-title":"Inflamm Allergy Drug Targets"},{"issue":"2","key":"386_CR172","doi-asserted-by":"crossref","first-page":"e526","DOI":"10.1542\/peds.2011-1900","volume":"132","author":"D D\u2019Agostino","year":"2013","unstructured":"D\u2019Agostino D, Costaguta A, \u00c1lvarez F. Successful treatment of refractory autoimmune hepatitis with rituximab. Pediatrics 2013; 132(2): e526\u2013e530","journal-title":"Pediatrics"},{"issue":"5","key":"386_CR173","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/2013\/512624","volume":"27","author":"KW Burak","year":"2013","unstructured":"Burak KW, Swain MG, Santodomingo-Garzon T, Lee SS, Urbanski SJ, Aspinall AI, Coffin CS, Myers RP. Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy. Can J Gastroenterol 2013; 27(5): 273\u2013280","journal-title":"Can J Gastroenterol"},{"issue":"5","key":"386_CR174","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00228-011-1191-4","volume":"68","author":"A Grasland","year":"2012","unstructured":"Grasland A, Sterpu R, Boussoukaya S, Mahe I. Autoimmune hepatitis induced by adalimumab with successful switch to abatacept. Eur J Clin Pharmacol 2012; 68(5): 895\u2013898","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"386_CR175","first-page":"133","volume":"59","author":"C Weiler-Normann","year":"2013","unstructured":"Weiler-Normann C, Sebode M, Lohse AW. Autoimmune hepatitis 2013 and beyond. Minerva Gastroenterol Dietol 2013; 59(2): 133\u2013141","journal-title":"Minerva Gastroenterol Dietol"},{"issue":"1","key":"386_CR176","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1097\/MPG.0b013e318291feaa","volume":"58","author":"J Kurowski","year":"2014","unstructured":"Kurowski J, Melin-Aldana H, Bass L, Alonso EM, Ekong UD. Sirolimus as rescue therapy in pediatric autoimmune hepatitis. J Pediatr Gastroenterol Nutr 2014; 58(1): e4\u2013e6","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"386_CR177","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/hep.510300603","volume":"30","author":"AJ Czaja","year":"1999","unstructured":"Czaja AJ, Carpenter HA, Lindor KD. Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial. Hepatology 1999; 30(6): 1381\u20131386","journal-title":"Hepatology"},{"issue":"5","key":"386_CR178","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1053\/gast.2000.0010000001","volume":"119","author":"AJ Czaja","year":"2000","unstructured":"Czaja AJ, Lindor KD. Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis. Gastroenterology 2000; 119(5): 1312\u20131316","journal-title":"Gastroenterology"},{"issue":"10","key":"386_CR179","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1155\/2010\/891252","volume":"24","author":"K Sharzehi","year":"2010","unstructured":"Sharzehi K, Huang MA, Schreibman IR, Brown KA. Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy. Can J Gastroenterol 2010; 24(10): 588\u2013592","journal-title":"Can J Gastroenterol"},{"issue":"9","key":"386_CR180","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cgh.2008.04.006","volume":"6","author":"JT Hlivko","year":"2008","unstructured":"Hlivko JT, Shiffman ML, Stravitz RT, Luketic VA, Sanyal AJ, Fuchs M, Sterling RK. A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis. Clin Gastroenterol Hepatol 2008; 6(9): 1036\u20131040","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"386_CR181","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/01.mcg.0000177260.72692.e8","volume":"39","author":"AJ Czaja","year":"2005","unstructured":"Czaja AJ, Carpenter HA. Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease. J Clin Gastroenterol 2005; 39(9): 819\u2013825","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"386_CR182","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1478-3231.2005.01107.x","volume":"25","author":"N Chatur","year":"2005","unstructured":"Chatur N, Ramji A, Bain VG, Ma MM, Marotta PJ, Ghent CN, Lilly LB, Heathcote EJ, Deschenes M, Lee SS, Steinbrecher UP, Yoshida EM. Transplant immunosuppressive agents in nontransplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus. Liver Int 2005; 25(4): 723\u2013727","journal-title":"Liver Int"},{"issue":"7","key":"386_CR183","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cgh.2007.02.030","volume":"5","author":"I Inductivo-Yu","year":"2007","unstructured":"Inductivo-Yu I, Adams A, Gish RG, Wakil A, Bzowej NH, Frederick RT, Bonacini M. Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy. Clin Gastroenterol Hepatol 2007; 5(7): 799\u2013802","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"386_CR184","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0168-8278(05)80615-4","volume":"21","author":"KE Sherman","year":"1994","unstructured":"Sherman KE, Narkewicz M, Pinto PC. Cyclosporine in the management of corticosteroid-resistant type I autoimmune chronic active hepatitis. J Hepatol 1994; 21(6): 1040\u20131047","journal-title":"J Hepatol"},{"issue":"1","key":"386_CR185","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1572-0241.1999.00807.x","volume":"94","author":"NF Fernandes","year":"1999","unstructured":"Fernandes NF, Redeker AG, Vierling JM, Villamil FG, Fong TL. Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis. Am J Gastroenterol 1999; 94(1): 241\u2013248","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"386_CR186","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-2036.2003.01754.x","volume":"19","author":"M Sciveres","year":"2004","unstructured":"Sciveres M, Caprai S, Palla G, Ughi C, Maggiore G. Effectiveness and safety of ciclosporin as therapy for autoimmune diseases of the liver in children and adolescents. Aliment Pharmacol Ther 2004; 19(2): 209\u2013217","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"386_CR187","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1023\/A:1010683817344","volume":"46","author":"R Malekzadeh","year":"2001","unstructured":"Malekzadeh R, Nasseri-Moghaddam S, Kaviani MJ, Taheri H, Kamalian N, Sotoudeh M. Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis. Dig Dis Sci 2001; 46(6): 1321\u20131327","journal-title":"Dig Dis Sci"},{"issue":"4","key":"386_CR188","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2174\/1568010023344526","volume":"1","author":"AJ Czaja","year":"2002","unstructured":"Czaja AJ. Emerging treatments for autoimmune hepatitis. Curr Drug Targets Inflamm Allergy 2002; 1(4): 317\u2013326","journal-title":"Curr Drug Targets Inflamm Allergy"},{"issue":"1","key":"386_CR189","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1053\/jhep.2002.30991","volume":"35","author":"MA Heneghan","year":"2002","unstructured":"Heneghan MA, McFarlane IG. Current and novel immunosuppressive therapy for autoimmune hepatitis. Hepatology 2002; 35(1): 7\u201313","journal-title":"Hepatology"},{"key":"386_CR190","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1089-3261(02)00029-6","volume":"6","author":"JM Vierling","year":"2002","unstructured":"Vierling JM, Flores PA. Evolving new therapies of autoimmune hepatitis. Clin Liver Dis 2002; 6: 825\u201350, ix","journal-title":"Clin Liver Dis"},{"issue":"29","key":"386_CR191","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.2174\/138161211798157568","volume":"17","author":"AJ Czaja","year":"2011","unstructured":"Czaja AJ. Promising pharmacological, molecular and cellular treatments of autoimmune hepatitis. Curr Pharm Des 2011; 17(29): 3120\u20133140","journal-title":"Curr Pharm Des"},{"issue":"9","key":"386_CR192","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1155\/2012\/512132","volume":"26","author":"AJ Czaja","year":"2012","unstructured":"Czaja AJ. Autoimmune hepatitis: focusing on treatments other than steroids. Can J Gastroenterol 2012; 26(9): 615\u2013620","journal-title":"Can J Gastroenterol"},{"issue":"5","key":"386_CR193","first-page":"771","volume":"90","author":"DH Thiel Van","year":"1995","unstructured":"Van Thiel DH, Wright H, Carroll P, Abu-Elmagd K, Rodriguez-Rilo H, McMichael J, Irish W, Starzl TE. Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial. Am J Gastroenterol 1995; 90(5): 771\u2013776","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"386_CR194","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/01.mcg.0000139050.67178.be","volume":"38","author":"BA Aqel","year":"2004","unstructured":"Aqel BA, Machicao V, Rosser B, Satyanarayana R, Harnois DM, Dickson RC. Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis. J Clin Gastroenterol 2004; 38(9): 805\u2013809","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"386_CR195","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2036.2011.04749.x","volume":"34","author":"MM Tannous","year":"2011","unstructured":"Tannous MM, Cheng J, Muniyappa K, Farooq I, Bharara A, Kappus M, Luketic V, Stravtiz RT, Fuchs M, Puri P, Sanyal A, Sterling R. Use of tacrolimus in the treatment of autoimmune hepatitis: a single centre experience. Aliment Pharmacol Ther 2011; 34(3): 405\u2013407","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"386_CR196","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1600-6143.2005.00801.x","volume":"5","author":"N Kerkar","year":"2005","unstructured":"Kerkar N, Dugan C, Rumbo C, Morotti RA, Gondolesi G, Shneider BL, Emre S. Rapamycin successfully treats post-transplant autoimmune hepatitis. Am J Transplant 2005; 5(5): 1085\u20131089","journal-title":"Am J Transplant"},{"issue":"6","key":"386_CR197","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.transproceed.2011.05.028","volume":"43","author":"T Casanovas","year":"2011","unstructured":"Casanovas T, Argudo A, Pe\u00f1a-Cala MC. Effectiveness and safety of everolimus in the treatment of autoimmune hepatitis related to anti-hepatitis C virus therapy after liver transplant: three case reports. Transplant Proc 2011; 43(6): 2233\u20132236","journal-title":"Transplant Proc"},{"issue":"3","key":"386_CR198","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/157488611797579221","volume":"6","author":"R Moreno-Otero","year":"2011","unstructured":"Moreno-Otero R, Garc\u00eda-Buey L, Garc\u00eda-Sanchez A, Trapero-Marug\u00e1n M. Autoimmune hepatitis after long-term methotrexate therapy for rheumatoid arthritis. Curr Drug Saf 2011; 6(3): 197\u2013200","journal-title":"Curr Drug Saf"},{"issue":"3","key":"386_CR199","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1159\/000320410","volume":"28","author":"OS Khokhar","year":"2010","unstructured":"Khokhar OS, Lewis JH. Hepatotoxicity of agents used in the management of inflammatory bowel disease. Dig Dis 2010; 28(3): 508\u2013518","journal-title":"Dig Dis"},{"issue":"11","key":"386_CR200","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.4067\/S0034-98872011001100015","volume":"139","author":"EJ Carey","year":"2011","unstructured":"Carey EJ, Somaratne K, Rakela J. Successful rituximab therapy in refractory autoimmune hepatitis and Evans syndrome. Rev Med Chil 2011; 139(11): 1484\u20131487","journal-title":"Rev Med Chil"},{"issue":"5","key":"386_CR201","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1478-3231.2006.01262.x","volume":"26","author":"ES Santos","year":"2006","unstructured":"Santos ES, Arosemena LR, Raez LE, O\u2019Brien C, Regev A. Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature. Liver Int 2006; 26(5): 625\u2013629","journal-title":"Liver Int"},{"issue":"3","key":"386_CR202","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1159\/000322693","volume":"4","author":"E Barth","year":"2010","unstructured":"Barth E, Clawson J. A case of autoimmune hepatitis treated with rituximab. Case Rep Gastroenterol 2010; 4(3): 502\u2013509","journal-title":"Case Rep Gastroenterol"},{"issue":"3","key":"386_CR203","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ajg.2013.08.009","volume":"14","author":"SA Al-Busafi","year":"2013","unstructured":"Al-Busafi SA, Michel RP, Deschenes M. Rituximab for refractory autoimmune hepatitis: a case report. Arab J Gastroenterol 2013; 14(3): 135\u2013138","journal-title":"Arab J Gastroenterol"},{"issue":"3","key":"386_CR204","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2012.11.010","volume":"58","author":"C Weiler-Normann","year":"2013","unstructured":"Weiler-Normann C, Schramm C, Quaas A, Wiegard C, Glaubke C, Pannicke N, M\u00f6ller S, Lohse AW. Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis. J Hepatol 2013; 58(3): 529\u2013534","journal-title":"J Hepatol"},{"issue":"9","key":"386_CR205","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2169\/internalmedicine.51.6824","volume":"51","author":"K Fujii","year":"2012","unstructured":"Fujii K, Rokutanda R, Osugi Y, Koyama Y, Ota T. Adult-onset Still\u2019s disease complicated by autoimmune hepatitis: successful treatment with infliximab. Intern Med 2012; 51(9): 1125\u20131128","journal-title":"Intern Med"},{"issue":"3","key":"386_CR206","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11739-009-0342-4","volume":"5","author":"S Mancini","year":"2010","unstructured":"Mancini S, Amorotti E, Vecchio S, Ponz de Leon M, Roncucci L. Infliximab-related hepatitis: discussion of a case and review of the literature. Intern Emerg Med 2010; 5(3): 193\u2013200","journal-title":"Intern Emerg Med"},{"issue":"5","key":"386_CR207","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.crohns.2012.01.017","volume":"6","author":"C Casteren-Messidoro van","year":"2012","unstructured":"van Casteren-Messidoro C, Prins G, van Tilburg A, Zelinkova Z, Schouten J, de Man R. Autoimmune hepatitis following treatment with infliximab for inflammatory bowel disease. J Crohn\u2019s Colitis 2012; 6(5): 630\u2013631","journal-title":"J Crohn\u2019s Colitis"},{"issue":"1","key":"386_CR208","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/ajd.12054","volume":"55","author":"LJ Dang","year":"2014","unstructured":"Dang LJ, Lubel JS, Gunatheesan S, Hosking P, Su J. Drug-induced lupus and autoimmune hepatitis secondary to infliximab for psoriasis. Australas J Dermatol 2014; 55(1): 75\u201379","journal-title":"Australas J Dermatol"},{"issue":"3","key":"386_CR209","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.autrev.2012.03.010","volume":"12","author":"C Efe","year":"2013","unstructured":"Efe C. Drug induced autoimmune hepatitis and TNF-\u03b1 blocking agents: is there a real relationship? Autoimmun Rev 2013; 12(3): 337\u2013339","journal-title":"Autoimmun Rev"},{"issue":"4","key":"386_CR210","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/lt.22018","volume":"16","author":"C Schramm","year":"2010","unstructured":"Schramm C, Bubenheim M, Adam R, Karam V, Buckels J, O\u2019Grady JG, Jamieson N, Pollard S, Neuhaus P, Manns MM, Porte R, Castaing D, Paul A, Traynor O, Garden J, Friman S, Ericzon BG, Fischer L, Vitko S, Krawczyk M, Metselaar HJ, Foss A, Kilic M, Rolles K, Burra P, Rogiers X, Lohse AW. Primary liver transplantation for autoimmune hepatitis: a comparative analysis of the European Liver Transplant Registry. Liver Transpl 2010; 16(4): 461\u2013469","journal-title":"Liver Transpl"},{"issue":"9","key":"386_CR211","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1007\/s10620-012-2179-3","volume":"57","author":"AJ Czaja","year":"2012","unstructured":"Czaja AJ. Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation. Dig Dis Sci 2012; 57(9): 2248\u20132266","journal-title":"Dig Dis Sci"},{"issue":"3","key":"386_CR212","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1440-1746.2012.07125.x","volume":"28","author":"N Dbouk","year":"2013","unstructured":"Dbouk N, Parekh S. Impact of pretransplant antinuclear antibody and antismooth muscle antibody titers on disease recurrence and graft survival following liver transplantation in autoimmune hepatitis patients. J Gastroenterol Hepatol 2013; 28(3): 537\u2013542","journal-title":"J Gastroenterol Hepatol"},{"issue":"4Pt1","key":"386_CR213","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1053\/jhep.2000.19149","volume":"32","author":"MP Manns","year":"2000","unstructured":"Manns MP, Bahr MJ. Recurrent autoimmune hepatitis after liver transplantation-when non-self becomes self. Hepatology 2000; 32(4 Pt 1): 868\u2013870","journal-title":"Hepatology"},{"issue":"6","key":"386_CR214","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1053\/jlts.2002.33485","volume":"8","author":"AJ Czaja","year":"2002","unstructured":"Czaja AJ. Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance. Liver Transpl 2002; 8(6): 505\u2013513","journal-title":"Liver Transpl"},{"issue":"9","key":"386_CR215","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.4049\/jimmunol.173.9.5355","volume":"173","author":"HR Rosen","year":"2004","unstructured":"Rosen HR, Hinrichs DJ, Leistikow RL, Callender G, Wertheimer AM, Nishimura MI, Lewinsohn DM. Cutting edge: identification of hepatitis C virus-specific CD8+ T cells restricted by donor HLA alleles following liver transplantation. J Immunol 2004; 173(9): 5355\u20135359","journal-title":"J Immunol"},{"issue":"1","key":"386_CR216","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0168-8278(99)80017-8","volume":"30","author":"V Ratziu","year":"1999","unstructured":"Ratziu V, Samuel D, Sebagh M, Farges O, Saliba F, Ichai P, Farahmand H, Gigou M, F\u00e9ray C, Reyn\u00e8s M, Bismuth H. Longterm follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease. J Hepatol 1999; 30(1): 131\u2013141","journal-title":"J Hepatol"},{"issue":"2","key":"386_CR217","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1432-2277.2008.00729.x","volume":"22","author":"TC Schreuder","year":"2009","unstructured":"Schreuder TC, H\u00fcbscher SG, Neuberger J. Autoimmune liver diseases and recurrence after orthotopic liver transplantation: what have we learned so far? Transpl Int 2009; 22(2): 144\u2013152","journal-title":"Transpl Int"},{"issue":"6","key":"386_CR218","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/gut.52.6.893","volume":"52","author":"JC Duclos-Vall\u00e9e","year":"2003","unstructured":"Duclos-Vall\u00e9e JC, Sebagh M, Rifai K, Johanet C, Ballot E, Guettier C, Karam V, Hurtova M, Feray C, Reynes M, Bismuth H, Samuel D. A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence. Gut 2003; 52(6): 893\u2013897","journal-title":"Gut"},{"issue":"2","key":"386_CR219","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1053\/jhep.2000.9077","volume":"32","author":"G Ayata","year":"2000","unstructured":"Ayata G, Gordon FD, Lewis WD, Pomfret E, Pomposelli JJ, Jenkins RL, Khettry U. Liver transplantation for autoimmune hepatitis: a long-term pathologic study. Hepatology 2000; 32(2): 185\u2013192","journal-title":"Hepatology"},{"issue":"12","key":"386_CR220","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/lt.20910","volume":"12","author":"M Gautam","year":"2006","unstructured":"Gautam M, Cheruvattath R, Balan V. Recurrence of autoimmune liver disease after liver transplantation: a systematic review. Liver Transpl 2006; 12(12): 1813\u20131824","journal-title":"Liver Transpl"},{"issue":"2","key":"386_CR221","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00007890-199907270-00016","volume":"68","author":"P Milkiewicz","year":"1999","unstructured":"Milkiewicz P, Hubscher SG, Skiba G, Hathaway M, Elias E. Recurrence of autoimmune hepatitis after liver transplantation. Transplantation 1999; 68(2): 253\u2013256","journal-title":"Transplantation"},{"issue":"6","key":"386_CR222","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1053\/jlts.2001.24638","volume":"7","author":"M Hurtova","year":"2001","unstructured":"Hurtova M, Duclos-Vall\u00e9e JC, Johanet C, Emile JF, Roque-Afonso AM, Feray C, Bismuth H, Samuel D. Successful tacrolimus therapy for a severe recurrence of type 1 autoimmune hepatitis in a liver graft recipient. Liver Transpl 2001; 7(6): 556\u2013558","journal-title":"Liver Transpl"},{"issue":"4","key":"386_CR223","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/jlts.2001.21449","volume":"7","author":"A Gonz\u00e1lez-Koch","year":"2001","unstructured":"Gonz\u00e1lez-Koch A, Czaja AJ, Carpenter HA, Roberts SK, Charlton MR, Porayko MK, Rosen CB, Wiesner RH. Recurrent autoimmune hepatitis after orthotopic liver transplantation. Liver Transpl 2001; 7(4): 302\u2013310","journal-title":"Liver Transpl"},{"issue":"5","key":"386_CR224","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1432-2277.2007.00628.x","volume":"21","author":"IA Rowe","year":"2008","unstructured":"Rowe IA, Webb K, Gunson BK, Mehta N, Haque S, Neuberger J. The impact of disease recurrence on graft survival following liver transplantation: a single centre experience. Transpl Int 2008; 21(5): 459\u2013465","journal-title":"Transpl Int"},{"issue":"6","key":"386_CR225","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bpg.2011.09.008","volume":"25","author":"JA Ilyas","year":"2011","unstructured":"Ilyas JA, O\u2019Mahony CA, Vierling JM. Liver transplantation in autoimmune liver diseases. Best Pract Res Clin Gastroenterol 2011; 25(6): 765\u2013782","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"1","key":"386_CR226","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-0031-1272834","volume":"31","author":"M Guido","year":"2011","unstructured":"Guido M, Burra P. De novo autoimmune hepatitis after liver transplantation. Semin Liver Dis 2011; 31(1): 71\u201381","journal-title":"Semin Liver Dis"},{"issue":"9100","key":"386_CR227","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(97)06478-7","volume":"351","author":"N Kerkar","year":"1998","unstructured":"Kerkar N, Hadzi\u0107 N, Davies ET, Portmann B, Donaldson PT, Rela M, Heaton ND, Vergani D, Mieli-Vergani G. De-novo autoimmune hepatitis after liver transplantation. Lancet 1998; 351(9100): 409\u2013413","journal-title":"Lancet"},{"issue":"3","key":"386_CR228","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.26756","volume":"34","author":"MA Heneghan","year":"2001","unstructured":"Heneghan MA, Portmann BC, Norris SM, Williams R, Muiesan P, Rela M, Heaton ND, O\u2019Grady JG. Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults. Hepatology 2001; 34(3): 464\u2013470","journal-title":"Hepatology"},{"issue":"6","key":"386_CR229","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/j.1600-6143.2006.01333.x","volume":"6","author":"RC Verdonk","year":"2006","unstructured":"Verdonk RC, Dijkstra G, Haagsma EB, Shostrom VK, Van den Berg AP, Kleibeuker JH, Langnas AN, Sudan DL. Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease. Am J Transplant 2006; 6(6): 1422\u20131429","journal-title":"Am J Transplant"},{"issue":"3","key":"386_CR230","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.clim.2008.06.011","volume":"128","author":"DD Hampton","year":"2008","unstructured":"Hampton DD, Poleski MH, Onken JE. Inflammatory bowel disease following solid organ transplantation. Clin Immunol 2008; 128(3): 287\u2013293","journal-title":"Clin Immunol"},{"issue":"3","key":"386_CR231","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/hep.23792","volume":"52","author":"S Ferri","year":"2010","unstructured":"Ferri S, Longhi MS, De Molo C, Lalanne C, Muratori P, Granito A, Hussain MJ, Ma Y, Lenzi M, Mieli-Vergani G, Bianchi FB, Vergani D, Muratori L. A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology 2010; 52(3): 999\u20131007","journal-title":"Hepatology"},{"key":"386_CR232","doi-asserted-by":"crossref","first-page":"001","DOI":"10.1002\/hep.24039","volume":"53","author":"MS Longhi","year":"2011","unstructured":"Longhi MS, Hussain M, Mieli-Vergani G, Kwok W, Ma Y, Vergani D. Auto-antigen-specific regulatory T-cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis. Hepatology 2011; 53: 001\u2013002","journal-title":"Hepatology"},{"issue":"7","key":"386_CR233","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nri2785","volume":"10","author":"S Sakaguchi","year":"2010","unstructured":"Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 2010; 10(7): 490\u2013500","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"386_CR234","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nrrheum.2010.155","volume":"6","author":"H Schulze-Koops","year":"2010","unstructured":"Schulze-Koops H, Skapenko A. Inflammation: TREG cell control of autoimmune inflammation: a matter of timing? Nat Rev Rheumatol 2010; 6(11): 620\u2013621","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"386_CR235","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/ni.1818","volume":"11","author":"K Wing","year":"2010","unstructured":"Wing K, Sakaguchi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 2010; 11(1): 7\u201313","journal-title":"Nat Immunol"}],"container-title":["Frontiers of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11684-015-0386-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11684-015-0386-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11684-015-0386-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T19:27:15Z","timestamp":1747769235000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11684-015-0386-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,6]]},"references-count":235,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["386"],"URL":"https:\/\/doi.org\/10.1007\/s11684-015-0386-y","relation":{},"ISSN":["2095-0217","2095-0225"],"issn-type":[{"value":"2095-0217","type":"print"},{"value":"2095-0225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,6]]}}}